<DOC>
	<DOCNO>NCT02550418</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy 8 week treatment once-daily 9 mg budesonide patient active ulcerative colitis</brief_summary>
	<brief_title>Budesonide 9 mg Capsules Active UC</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Signed informed consent , Men woman age 18 75 year , Active ulcerative colitis , except proctitis limit 15 cm ab ano , confirm endoscopy histology , Established disease , Crohn 's disease , indeterminate colitis , ischaemic colitis , radiation colitis , microscopic colitis ( i.e. , collagenous colitis lymphocytic colitis , incomplete microscopic colitis ) , diverticular disease associate colitis , Toxic megacolon fulminant colitis , Colon resection , Evidence infectious colitis ( e.g. , pathogenic bacteria Clostridium difficile toxin stool culture screen ) , Malabsorption syndromes , Celiac disease , Bleeding hemorrhoid , Active peptic ulcer disease Other inflammatory bleed disorder colon intestine , disease may cause diarrhea gastrointestinal bleeding , Hypertension , diabetes mellitus , osteoporosis , peptic ulcer disease , glaucoma , cataract , infection careful medical monitoring ensure , Any severe infectious disease ( e.g. , tuberculosis , AIDS ) , Severe comorbidity substantially reduce life expectancy , History colorectal cancer , History cancer ( colorectal ) last 5 year , except basal cell carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>